Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuta Hoshi
Institutions:
National Cancer Center Hospital East,
Institute of Science Tokyo Hospital
Observed institutions:
Tokyo Medical and Dental University,
Saitama Cancer Center,
National Cancer Center Hospital East,
Institute of Science Tokyo Hospital,
Gunma Prefectural Cancer Center
ORCID:
0009-0008-5652-6665
Observed ORCID:
0009-0008-5652-6665
OpenAlex ID:
A5059771699
Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
2023
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
Frontiers in Oncology
·
16
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck
2023
·
Hideki Tanaka
, Tomohiro Enokida
, et al.
·
Frontiers in Oncology
·
13
PDF
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer
2024
·
Takashi Hirai
, Yujiro Naito
, et al.
·
JCI Insight
·
12
PDF
Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma
2024
·
Yuta Hoshi
, Tomohiro Enokida
, et al.
·
Frontiers in Oncology
·
11
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer
2025
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
International Journal of Clinical Oncology
·
6
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer
2024
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
International Journal of Clinical Oncology
·
6
Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan
2025
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
Thyroid
·
5
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
2023
·
Naohiro Takeshita
, Tomohiro Enokida
, et al.
·
Oral Oncology
·
5
Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy
2025
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
Oral Oncology
·
4
LH–RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study
2025
·
Takuma Kishida
, Tomohiro Enokida
, et al.
·
International Journal of Clinical Oncology
·
3
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab
2023
·
Yuta Hoshi
, Satoshi Shirakura
, et al.
·
International Journal of Clinical Oncology
·
3
Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma
2025
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
Auris Nasus Larynx
·
1
Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)
2025
·
Nobukazu Tanaka
, Tomohiro Enokida
, et al.
·
Oral Oncology
·
1
Significance of imaging-detected extranodal extension (iENE) in locally advanced head and neck squamous cell carcinoma (LASCCHN) treated with induction chemotherapy followed by chemoradiotherapy.
2024
·
Ryutaro Onaga
, Tomohiro Enokida
, et al.
·
Journal of Clinical Oncology
·
1
Prognostic significance of imaging-detected extranodal extension (iENE) in pathological ENE-negative head and neck squamous cell carcinoma.
2026
·
Ryo Kuboki
, Tomohiro Enokida
, et al.
·
Journal of Clinical Oncology
Significance of Preoperative Imaging‐Detected Extranodal Extension in Pathological Extranodal Extension‐Positive Head and Neck Squamous Cell Carcinoma Treated With Postoperative Chemoradiotherapy
2026
·
Yuta Hoshi
, Hirofumi Kuno
, et al.
·
Head & Neck
Abdominal Wall Abscess after Prophylactic Percutaneous Endoscopic Gastrostomy Placement in a Patient Undergoing Chemoradiotherapy for Laryngeal Cancer
2026
·
Ryuji Okamoto
, Hironori Sunakawa
, et al.
·
DEN Open
PDF
Prognostic impact of preoperative imaging-detected extranodal extension in head and neck squamous cell carcinoma treated with postoperative chemoradiotherapy.
2025
·
Yuta Hoshi
, Hirofumi Kuno
, et al.
·
Journal of Clinical Oncology
PDF
O9-2 Salvage chemotherapy with paclitaxel plus cetuximab (PE)-based regimen following immune checkpoint inhibitor in R/M SCCHN
2023
·
Hideki Tanaka
, Tomohiro Enokida
, et al.
·
Annals of Oncology
PDF
MO43-1 The treatment sequence of weekly paclitaxel, carboplatin, and cetuximab (PCE) followed by nivolumab for R/M SCCHN
2023
·
Naohiro Takeshita
, Tomohiro Enokida
, et al.
·
Annals of Oncology
A case of untreated p16 positive oropharyngeal cancer during 9 years
2020
·
Yuta Hoshi
, Masami Suzuki
·
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
PDF
Show more works
View as search
Works count:
21
Citation count:
87
H-index:
6
I10-index:
4
Year
Topic
Type